These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 10984610)

  • 1. Tissue factor pathway inhibitor-2 suppresses the production of active matrix metalloproteinase-2 and is down-regulated in cells harboring activated ras oncogenes.
    Izumi H; Takahashi C; Oh J; Noda M
    FEBS Lett; 2000 Sep; 481(1):31-6. PubMed ID: 10984610
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prokaryotic expression, purification, and reconstitution of biological activities (Antiprotease, antitumor, and heparin-binding) for tissue factor pathway inhibitor-2.
    Rao CN; Reddy P; Reeder DJ; Liu Y; Stack SM; Kisiel W; Woodley DT
    Biochem Biophys Res Commun; 2000 Oct; 276(3):1286-94. PubMed ID: 11027624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Degradation of endothelial cell matrix collagen is correlated with induction of stromelysin by an activated ras oncogene.
    LoSardo JE; Goggin BS; Bohoslawec O; Neri A
    Clin Exp Metastasis; 1995 Jul; 13(4):236-48. PubMed ID: 7606886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ras-transfection up-regulated HaCaT cell migration: inhibition by Marimastat.
    Charvat S; Le Griel C; Chignol MC; Schmitt D; Serres M
    Clin Exp Metastasis; 1999; 17(8):677-85. PubMed ID: 10919713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tissue factor pathway inhibitor-2 is downregulated by ox-LDL and inhibits ox-LDL induced vascular smooth muscle cells proliferation and migration.
    Zhao B; Luo X; Shi H; Ma D
    Thromb Res; 2011 Aug; 128(2):179-85. PubMed ID: 21458846
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of serine proteinase inhibitor PP5/TFPI-2/MSPI decreases the invasive potential of human choriocarcinoma cells in vitro and in vivo.
    Jin M; Udagawa K; Miyagi E; Nakazawa T; Hirahara F; Yasumitsu H; Miyazaki K; Nagashima Y; Aoki I; Miyagi Y
    Gynecol Oncol; 2001 Nov; 83(2):325-33. PubMed ID: 11606093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppression of invasion and MMP-9 expression in NIH 3T3 and v-H-Ras 3T3 fibroblasts by lovastatin through inhibition of ras isoprenylation.
    Wang IK; Lin-Shiau SY; Lin JK
    Oncology; 2000 Sep; 59(3):245-54. PubMed ID: 11053993
    [TBL] [Abstract][Full Text] [Related]  

  • 8. R-Ras promotes tumor growth of cervical epithelial cells.
    Rincón-Arano H; Rosales R; Mora N; Rodriguez-Castañeda A; Rosales C
    Cancer; 2003 Feb; 97(3):575-85. PubMed ID: 12548599
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TFPI-2 silencing increases tumour progression and promotes metalloproteinase 1 and 3 induction through tumour-stromal cell interactions.
    Gaud G; Iochmann S; Guillon-Munos A; Brillet B; Petiot S; Seigneuret F; Touzé A; Heuzé-Vourc'h N; Courty Y; Lerondel S; Gruel Y; Reverdiau P
    J Cell Mol Med; 2011 Feb; 15(2):196-208. PubMed ID: 20015200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. cDNA cloning and mRNA expression of a serine proteinase inhibitor secreted by cancer cells: identification as placental protein 5 and tissue factor pathway inhibitor-2.
    Miyagi Y; Koshikawa N; Yasumitsu H; Miyagi E; Hirahara F; Aoki I; Misugi K; Umeda M; Miyazaki K
    J Biochem; 1994 Nov; 116(5):939-42. PubMed ID: 7896752
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of matrix metalloproteinase-9 and inhibition of tumor invasion by the membrane-anchored glycoprotein RECK.
    Takahashi C; Sheng Z; Horan TP; Kitayama H; Maki M; Hitomi K; Kitaura Y; Takai S; Sasahara RM; Horimoto A; Ikawa Y; Ratzkin BJ; Arakawa T; Noda M
    Proc Natl Acad Sci U S A; 1998 Oct; 95(22):13221-6. PubMed ID: 9789069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transient RNA silencing of tissue factor pathway inhibitor-2 modulates lung cancer cell invasion.
    Iochmann S; Bléchet C; Chabot V; Saulnier A; Amini A; Gaud G; Gruel Y; Reverdiau P
    Clin Exp Metastasis; 2009; 26(5):457-67. PubMed ID: 19267203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclic AMP-regulated synthesis of the tissue inhibitors of metalloproteinases suppresses the invasive potential of the human fibrosarcoma cell line HT1080.
    Tanaka K; Iwamoto Y; Ito Y; Ishibashi T; Nakabeppu Y; Sekiguchi M; Sugioka Y
    Cancer Res; 1995 Jul; 55(13):2927-35. PubMed ID: 7796421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human tissue factor pathway inhibitor-2 does not bind or inhibit activated matrix metalloproteinase-1.
    Du X; Chand HS; Kisiel W
    Biochim Biophys Acta; 2003 Jun; 1621(3):242-5. PubMed ID: 12787920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential expression of matrix metalloproteinases in activated c-ras-Ha-transfected immortalized human keratinocytes.
    Meade-Tollin LC; Boukamp P; Fusenig NE; Bowen CP; Tsang TC; Bowden GT
    Br J Cancer; 1998 Mar; 77(5):724-30. PubMed ID: 9514050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Defining the critical gene expression changes associated with expression and suppression of the tumorigenic and metastatic phenotype in Ha-ras-transformed cloned rat embryo fibroblast cells.
    Su ZZ; Austin VN; Zimmer SG; Fisher PB
    Oncogene; 1993 May; 8(5):1211-9. PubMed ID: 8479744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oncogenes and Angiogenesis: down-regulation of thrombospondin-1 in normal fibroblasts exposed to factors from cancer cells harboring mutant ras.
    Kalas W; Yu JL; Milsom C; Rosenfeld J; Benezra R; Bornstein P; Rak J
    Cancer Res; 2005 Oct; 65(19):8878-86. PubMed ID: 16204059
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extracellular matrix-associated serine protease inhibitors (Mr 33,000, 31,000, and 27,000) are single-gene products with differential glycosylation: cDNA cloning of the 33-kDa inhibitor reveals its identity to tissue factor pathway inhibitor-2.
    Rao CN; Reddy P; Liu Y; O'Toole E; Reeder D; Foster DC; Kisiel W; Woodley DT
    Arch Biochem Biophys; 1996 Nov; 335(1):82-92. PubMed ID: 8914837
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transient alterations in the expression of protease and extracellular matrix genes during metastatic lung colonization by H-ras-transformed 10T1/2 fibroblasts.
    Gingras MC; Jarolim L; Finch J; Bowden GT; Wright JA; Greenberg AH
    Cancer Res; 1990 Jul; 50(13):4061-6. PubMed ID: 2191771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Subtraction cloning of H-rev107, a gene specifically expressed in H-ras resistant fibroblasts.
    Hajnal A; Klemenz R; Schäfer R
    Oncogene; 1994 Feb; 9(2):479-90. PubMed ID: 8290259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.